Metastatic ovarian epithelial cancer represents the most advanced stage of this disease, where cancer cells have spread beyond the ovaries to distant organs. Understanding this condition, its symptoms, and available treatment approaches is essential for patients and their families facing this challenging diagnosis.
Understanding Metastatic Ovarian Epithelial Cancer
Metastatic ovarian cancer occurs when cancer that began in the ovaries, fallopian tubes, or the tissue lining the abdomen has spread to distant parts of the body. This advanced form of the disease is classified as Stage IV ovarian cancer. When cancer cells move from their original location to other organs, healthcare professionals still refer to it as ovarian cancer, even though it has reached places like the liver, lungs, or other distant sites.[1][2]
Epithelial ovarian cancer is the most common type of ovarian cancer, accounting for more than 90% of all ovarian cancer cases. This type develops in the thin layer of tissue that covers the outside of the ovaries, known as the epithelial tissue. Because of their similarities, cancers of the fallopian tubes and the peritoneum (the tissue lining the abdominal cavity) are often grouped together with epithelial ovarian cancer and treated in the same way.[3][4]
The disease progresses in stages, and understanding where cancer spreads helps doctors plan treatment. While there is no single path for how ovarian cancer spreads, most cases follow a similar pattern. The cancer typically moves from the ovaries to the pelvis, then to more distant parts of the abdomen and peritoneal cavity. From there, it can reach the lymph nodes and eventually distant organs such as the liver, lungs, or even bones and brain.[2][7]
Stage IV metastatic ovarian cancer is divided into two groups. Stage 4a means the cancer has caused fluid to build up in the lining of the lungs, called a malignant pleural effusion. Stage 4b indicates that cancer has spread to the inside of the liver or spleen, lymph nodes outside the abdomen, or other organs such as the lungs.[6][23]
Epidemiology
Ovarian cancer is the leading cause of death among women diagnosed with gynecological cancers in the United States. It ranks as the second most common gynecologic malignancy in the United States and the third most common worldwide. Globally, ovarian cancer is diagnosed in approximately 300,000 people each year and causes roughly 180,000 deaths.[1][16]
In the United States, an estimated 19,710 people will receive a diagnosis of ovarian cancer each year, with about 13,000 deaths annually. The high mortality rate associated with ovarian cancer is largely due to late detection. Only about 17% to 20% of ovarian cancers are detected before the disease has spread beyond the ovaries. More than half of all ovarian cancer cases are diagnosed in later stages, when the cancer has already metastasized to distant organs.[7][16]
Among women initially diagnosed with Stage IV ovarian cancer, survival rates vary depending on the specific type of cancer. For invasive epithelial ovarian cancer, the five-year relative survival rate is 31%. This means that women with this stage of cancer are 31% as likely to live at least five years compared to women without the cancer. For other types like germ cell tumors of the ovary, the rate is higher at 71%, and for ovarian stromal tumors, it is 70%.[18]
Age plays a significant role in ovarian cancer diagnosis. More than half of all ovarian cancer diagnoses occur in people over the age of 65 who have gone through menopause. The disease can affect younger women as well, but the risk increases substantially with age.[3][15]
Causes
Epithelial ovarian cancers develop when changes occur in a cell’s DNA, causing it to grow abnormally and out of control. These changes, called mutations, can make cells multiply too rapidly or prevent them from repairing damage properly. However, the exact reason why these cancers develop remains largely unknown.[3][15]
Experts now believe that many ovarian cancers actually start in cells at the end of the fallopian tubes, near the ovary. Once these abnormal cells reach the ovaries, they can spread quickly. In some cases, cancer begins in the peritoneum (the tissue lining the abdominal cavity) and then spreads to the ovaries. Because these cancers look similar under a microscope and spread in similar patterns, they are all treated as ovarian cancer.[3][5]
Other hereditary conditions can also increase risk, such as hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome. More often, however, ovarian cancer is caused by acquired gene changes that develop in cells during a person’s lifetime rather than being inherited from parents.[5]
Risk Factors
Several factors can increase a person’s chance of developing ovarian cancer. A family history of ovarian cancer is one of the most significant risk factors. Women who have a first-degree relative—such as a mother, daughter, or sister—with ovarian cancer face an elevated risk. The presence of inherited changes in the BRCA1 or BRCA2 genes substantially increases this risk.[4][5]
Other risk factors include certain medical conditions. Women with endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, are at higher risk for certain types of epithelial ovarian cancer, including endometrioid carcinoma and ovarian clear cell carcinoma. People of Asian descent also face higher risk for clear cell carcinoma.[3][15]
Lifestyle and reproductive factors also play a role. Obesity, defined as having a body mass index greater than 30, increases risk. The use of postmenopausal hormone therapy has been linked to higher ovarian cancer rates. Even tall height has been identified as a risk factor, though the reasons for this are not fully understood. Older age remains the primary risk factor for most cancers, including ovarian cancer, as the chance of developing cancer increases with age.[5]
Symptoms
One of the most challenging aspects of ovarian cancer is that it rarely causes noticeable symptoms in its early stages. This is why most cases are diagnosed only after the disease has already spread. As the cancer progresses and reaches more distant organs, symptoms become more apparent and difficult to ignore.[3][15]
As epithelial ovarian cancer spreads into the peritoneum, fluid can accumulate in the abdomen. This buildup of fluid causes several uncomfortable symptoms. Women may experience abdominal pain and bloating that persists over time. They may also feel full very quickly after eating, even after consuming only small amounts of food. Nausea, vomiting, and pelvic pain are also common complaints.[3][4]
Over 70% of people with early ovarian cancer report pain in the abdomen or pelvis. This pain can vary in nature—it may be dull and constant or it may come and go with intense episodes. Some women describe the sensation as similar to premenstrual syndrome, making it easy to dismiss as a less serious problem.[7]
Less common symptoms include changes in bowel habits, a strong urge to urinate or urinating more frequently than usual, and vaginal bleeding. As cancer spreads to other organs during metastasis, new symptoms can appear depending on which organs are affected. For example, if cancer reaches the lungs, a person may experience shortness of breath or persistent cough.[3][7]
Unfortunately, these symptoms are often vague and can be mistaken for less serious digestive issues such as gas, constipation, or bloating. This is one reason why ovarian cancer frequently progresses significantly before a diagnosis is made. Women experiencing persistent or worsening symptoms should seek medical attention promptly.[7][16]
Prevention
While it is not possible to prevent all cases of ovarian cancer, certain strategies may reduce risk. Women with a family history of ovarian or breast cancer should discuss their risk with their healthcare provider. Genetic testing can identify inherited mutations in BRCA1, BRCA2, or other genes linked to ovarian cancer. Knowing one’s genetic status allows for informed decision-making about preventive measures.[4][5]
For women at significantly increased risk due to inherited gene mutations, preventive surgery may be an option. This typically involves removing both ovaries and fallopian tubes, a procedure called risk-reducing salpingo-oophorectomy. While this surgery significantly lowers the risk of developing ovarian cancer, it does not eliminate the risk entirely, and it has other health implications such as early menopause. Women considering this option should have thorough discussions with their doctors about the benefits and risks.[4][5]
Unfortunately, no screening tests have been demonstrated to improve early detection and outcomes for ovarian cancer in the general population. Tests such as pelvic examinations, transvaginal ultrasound, and tumor marker testing (like CA-125 blood tests) may be used to evaluate women with symptoms or those at high risk, but they are not recommended as routine screening tools for women without risk factors.[16]
Getting regular gynecological exams and being aware of the warning signs of ovarian cancer are important steps for early detection. Women should not ignore persistent symptoms like bloating, pelvic pain, difficulty eating, or urinary urgency. Reporting these symptoms to a healthcare provider can lead to earlier diagnosis and potentially better outcomes.[3]
Pathophysiology
Ovarian cancer develops through complex biological processes that involve the transformation of normal cells into malignant ones. In epithelial ovarian cancer, the disease often begins with subtle changes in the cells lining the outside of the ovaries or the fallopian tubes. Over time, these cells accumulate genetic mutations that disrupt normal growth patterns and allow uncontrolled cell division.[1]
One of the most aggressive subtypes is high-grade serous carcinoma (HGSOC), which accounts for three out of four epithelial ovarian cancers. Experts believe HGSOC grows slowly at first, typically starting in the fallopian tubes. Once the cancer reaches the ovaries, it spreads rapidly. Nearly 70% of HGSOC cases are already at stage 3 or 4 by the time they are diagnosed, meaning the cancer has spread to nearby organs, lymph nodes, or distant sites.[3][15]
Other subtypes of epithelial ovarian cancer have different growth patterns and characteristics. For instance, low-grade serous ovarian carcinoma grows slowly over a long period, while clear cell carcinoma and mucinous carcinoma have their own distinct biological behaviors. Understanding these differences is important because they influence how the cancer responds to treatment.[3]
As ovarian cancer progresses, cancer cells can break away from the primary tumor and spread through several pathways. They can invade nearby structures in the pelvis, such as the uterus, bladder, or rectum. Cancer cells can also float in the fluid that naturally exists in the abdominal cavity, allowing them to implant on the peritoneum and other abdominal organs. Additionally, cancer cells can enter the lymphatic system or bloodstream and travel to distant organs like the liver, lungs, or bones.[2][7]
At the molecular level, ovarian cancers show distinct genetic patterns. High-grade serous carcinomas frequently have mutations in the TP53 gene (more than 80% of cases) and amplification of the CCNE1 gene that encodes cyclin E1. Other subtypes have different genetic signatures. For example, clear cell and endometrioid carcinomas are more commonly associated with mutations in genes like KRAS, BRAF, PTEN, and PIK3CA.[1][13]
The spread of ovarian cancer to distant organs marks the transition to metastatic disease. The liver is the most common distant organ for metastasis, followed by distant lymph nodes, lungs, bones, and brain. When cancer reaches these locations, it can disrupt normal organ function, leading to serious complications and symptoms that significantly impact quality of life.[7]
